DBV Technologies S.A. DPO Ratio 2011-2026 | DBVT

Annual DPO Ratio DBV Technologies S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	28.6 K	5.02 K	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
28.6 K	5.02 K	16.8 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Adaptive Biotechnologies Corporation ADPT	37.9	$ 18.24	-1.41 %	$ 2.68 B	USA
Amgen AMGN	49.6	$ 344.45	0.75 %	$ 185 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Biogen BIIB	65.4	$ 178.43	-0.81 %	$ 26 B	USA
Aytu BioScience AYTU	186	$ 2.7	3.85 %	$ 17 M	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Akebia Therapeutics AKBA	80.4	$ 1.39	-1.42 %	$ 261 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Cardiff Oncology CRDF	406	$ 1.75	-0.29 %	$ 83.4 M	USA
Compugen Ltd. CGEN	123	$ 1.85	0.54 %	$ 166 M	Israel
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
Amneal Pharmaceuticals AMRX	21.1	$ 14.11	3.14 %	$ 4.36 B	USA
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
BioCryst Pharmaceuticals BCRX	484	$ 6.64	0.91 %	$ 1.37 B	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands